ELIZABETH ANGELLIS: Open Payments
NPI 1801247903 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 10 payments from 7 companies in 2025. Trend: 2023 $1,049 · 2024 $1,105 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $151 |
| Medtronic, Inc. | 1 | $146 |
| E.R. Squibb & Sons, L.L.C. | 1 | $96 |
| ABIOMED | 1 | $94 |
| PFIZER INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Kerendia, SIMULUS, WAINUA, LOKELMA, CAMZYOS, ELIQUIS, LEQVIO.
Industry payments across KY — which companies pay providers there.
